Solid Biosciences Inc.

SLDB Nasdaq CIK: 0001707502

Company Information

Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 500 RUTHERFORD AVENUE, CHARLESTOWN, MA, 02129
Mailing Address 500 RUTHERFORD AVENUE, CHARLESTOWN, MA, 02129
Phone 617-337-4680
Fiscal Year End 1231
EIN 900943402

Financial Overview

FY2025

$52.53M
Total Liabilities

Recent SEC Filings

Form Type Date Filed Document
4 Insider stock transaction report April 2, 2026 View on SEC
S-3 Shelf registration for future offerings March 19, 2026 View on SEC
S-3 Shelf registration for future offerings March 19, 2026 View on SEC
10-K Annual financial report March 19, 2026 View on SEC
SCHEDULE 13D/A Beneficial ownership amendment March 17, 2026 View on SEC
8-K Current report of material events March 12, 2026 View on SEC
4 Insider stock transaction report March 11, 2026 View on SEC
SCHEDULE 13D/A Beneficial ownership amendment March 11, 2026 View on SEC
SCHEDULE 13D/A Beneficial ownership amendment March 10, 2026 View on SEC
SCHEDULE 13D/A Beneficial ownership amendment March 10, 2026 View on SEC

Annual Reports

10-K March 19, 2026
  • SGT-501 program received significant FDA designations (Fast Track, Orphan Drug, Rare Pediatric Disease), potentially accelerating development and offering commercial benefits.
  • Proprietary POLARIS-101TM AAV capsid is validated by clinical data and licensed to over 50 external groups, demonstrating its broad utility and value.
View Analysis

Insider Trading

STRONG SELL 7 insiders 27 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 2836)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.